iBio to Report Fiscal 2022 Second Quarter Financial Results

07.02.2022 - BRYAN, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) - iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System, announced today that ...

Related Keywords

Texas , United States , Stephen Kilmer , Fastpharming Contract Development , Manufacturing Services , Bio Inc , Glycaneering Development Services , Report Fiscal , Quarter Financial Results , Provide Corporate Update , Fastpharming Manufacturing System , Fastpharming System ,